SELLAS Life Sciences (SLS) Enterprise Value (2010 - 2026)
SELLAS Life Sciences (SLS) reported Enterprise Value of -$100000.0 for Q1 2026, little changed year-over-year from -$100000.0 in Q1 2025, and little changed on a QoQ basis from -$100000.0 in Q4 2025.
SELLAS Life Sciences (SLS) has 17 years of Enterprise Value data on file, last reported at -$100000.0 in Q1 2026.
- Quarterly Enterprise Value changed 0.0% year-over-year to -$100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$100000.0 (changed 0.0% YoY) and the FY2025 annual result came in at -$100000.0, up 99.28% from the prior year.
- Enterprise Value steadied at -$100000.0 in Q1 2026 per SLS's latest filing, from -$100000.0 in the prior quarter.
- Across five years, Enterprise Value topped out at -$100000.0 in Q1 2022 and bottomed at -$44.3 million in Q3 2025.
- The 5-year median for Enterprise Value is -$100000.0 (2022), against an average of -$6.3 million.
- The widest annual swing landed in 2022, when Enterprise Value jumped 99.64%; it then plunged 44220.0% in 2025.
- Tracing SLS's Enterprise Value over 5 years: stood at -$17.1 million in 2022, then surged by 85.23% to -$2.5 million in 2023, then slumped by 448.85% to -$13.9 million in 2024, then jumped by 99.28% to -$100000.0 in 2025, then changed by 0.0% to -$100000.0 in 2026.
- Per Business Quant, the three latest SLS Enterprise Value figures stand at -$100000.0 (Q1 2026), -$100000.0 (Q4 2025), and -$44.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -3.01 Bn |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | -100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -100,000.00 |
| Dec 31, 2025 | -100,000.00 |
| Sep 30, 2025 | -44.32 Mn |
| Jun 30, 2025 | -100,000.00 |
| Mar 31, 2025 | -100,000.00 |
| Dec 31, 2024 | -13.89 Mn |
| Sep 30, 2024 | -100,000.00 |
| Jun 30, 2024 | -100,000.00 |
| Mar 31, 2024 | -100,000.00 |
| Dec 31, 2023 | -2.53 Mn |
| Sep 30, 2023 | -3.97 Mn |
| Jun 30, 2023 | -100,000.00 |
| Mar 31, 2023 | -23.90 Mn |
| Dec 31, 2022 | -17.13 Mn |
| Sep 30, 2022 | -100,000.00 |
| Jun 30, 2022 | -100,000.00 |
| Mar 31, 2022 | -100,000.00 |
| Dec 31, 2021 | -21.36 Mn |
| Sep 30, 2021 | -26.30 Mn |
| Jun 30, 2021 | -100,000.00 |
| Mar 31, 2021 | -28.00 Mn |
| Dec 31, 2020 | -35.30 Mn |
| Sep 30, 2020 | -8.20 Mn |
| Jun 30, 2020 | -3.30 Mn |
| Mar 31, 2020 | -100,000.00 |
| Dec 31, 2019 | -100,000.00 |
| Sep 30, 2019 | -115,000.00 |
| Jun 30, 2019 | -100,000.00 |
| Mar 31, 2019 | -2.58 Mn |
| Dec 31, 2018 | -5.34 Mn |
| Sep 30, 2018 | -100,000.00 |
| Jun 30, 2018 | -8.60 Mn |
| Mar 31, 2018 | -8.61 Mn |
| Dec 31, 2017 | -12.75 Mn |
| Sep 30, 2017 | -12.90 Mn |
| Jun 30, 2017 | -13.60 Mn |
| Mar 31, 2017 | -18.10 Mn |
| Dec 31, 2016 | -6.05 Mn |
| Sep 30, 2016 | -24.51 Mn |
| Jun 30, 2016 | -19.59 Mn |
| Mar 31, 2016 | -401,000.00 |
| Dec 31, 2015 | -1.40 Mn |
| Sep 30, 2015 | -34.71 Mn |
| Jun 30, 2015 | -45.28 Mn |
| Mar 31, 2015 | -52.86 Mn |
| Dec 31, 2014 | -23.65 Mn |
| Sep 30, 2014 | -24.65 Mn |
| Jun 30, 2014 | -39.16 Mn |
| Mar 31, 2014 | -52.43 Mn |
| Dec 31, 2013 | -47.79 Mn |
| Sep 30, 2013 | -51.40 Mn |
| Jun 30, 2013 | -20.92 Mn |
| Mar 31, 2013 | -17.48 Mn |
| Dec 31, 2012 | -32.81 Mn |
| Sep 30, 2012 | -51.40 Mn |
| Jun 30, 2012 | -19.23 Mn |
| Mar 31, 2012 | -8.70 Mn |
| Dec 31, 2011 | -47.79 Mn |
| Sep 30, 2011 | -15.69 Mn |
| Jun 30, 2011 | -17.93 Mn |
| Mar 31, 2011 | -11.12 Mn |
| Dec 31, 2010 | -6.89 Mn |
| Sep 30, 2010 | -2.84 Mn |
| Jun 30, 2010 | -5.09 Mn |